This Week in Infectious Disease: Microbiome Therapies and Antibiotic Resistance

This week's research highlights emerging strategies for managing inflammatory conditions and addressing antimicrobial challenges. From the New England Journal of Medicine, a trial examined the potential of targeting the microbial-metabolic axis for patients with inflammatory bowel disease, suggesting that microbiome-targeting therapies represent emerging options for management ^[1].

Meanwhile, attention turned to diagnostic workflows, where a review in Frontiers in Medicine evaluated various enrichment methods, including PCR-based and CRISPR-Cas9 techniques, against shotgun sequencing. The authors note that these enrichment techniques may compromise the hypothesis-free nature of shotgun mNGS ^[2].

Elsewhere this week, researchers in Frontiers in Medicine explored the role of Wnt/β-catenin signaling in T cell biology. They describe how activation of this pathway promotes memory stem cell formation, proposing it as a potential target to enhance CAR-T cell persistence in hematologic cancers. However, the review indicates that clinical data on this approach remain preliminary ^[3].

We also saw research in Frontiers in Medicine linking SARS-CoV-2 infection to intestinal microbiome disruption. The study finds that the virus can induce dysbiosis and modify immune signaling, affecting neuropsychiatric outcomes, which suggests an observational link between the infection, gut changes, and immune effects relevant for pandemic planning ^[5].

A separate study in Emerging microbes & infections addressed critical issues regarding carbapenem therapy. A meta-analysis synthesized data on carbapenem use for monomicrobial OXA-48-producing Enterobacterales infections, analyzing a French cohort of 59 patients alongside other data. The findings suggest that carbapenems are linked to higher clinical failure in these specific infections. Consequently, the authors recommend prioritizing alternative active agents over carbapenems for treating OXA-48-PE infections ^[4].

Collectively, these studies offer a snapshot of current investigative directions in infectious disease management.